Contact
searchSearch
HMP Global

March 2011 - FRMC

Department

News Connection
Behavioral Therapy in Prostatectomy Patients with Persistent, Long-Term Incontinence
03/21/2011
Men with postoperative incontinence issues persisting at least 1 year after receiving a radical prostatectomy were found to have fewer incontinence episodes after 8 weeks of behavioral therapy when compared with a control group; however,...
Men with postoperative incontinence issues persisting at least 1 year after receiving a radical prostatectomy were found to have fewer incontinence episodes after 8 weeks of behavioral therapy when compared with a control group; however,...
Men with postoperative...
03/21/2011
First Report Managed Care
Conference Insider
Goal-Directed Fluid Replacement Strategy in Major Abdominal Surgical Patients
03/21/2011
In patients undergoing major abdominal surgery, optimal perioperative fluid management remains challenging, according to researchers. Adequate tissue perfusion is an essential component of oxygenation and can improve postoperative outcomes....
In patients undergoing major abdominal surgery, optimal perioperative fluid management remains challenging, according to researchers. Adequate tissue perfusion is an essential component of oxygenation and can improve postoperative outcomes....
In patients undergoing major...
03/21/2011
First Report Managed Care
News Connection
Monitoring and Treating Multiple Sclerosis: Advances in 2010
03/21/2011
Treatment and monitoring of patients with multiple sclerosis (MS) made important strides in 2010, according to a review in Nature [2011;7:74-75]. Magnetic resonance imaging (MRI) and immunologic biomarkers were identified to track the...
Treatment and monitoring of patients with multiple sclerosis (MS) made important strides in 2010, according to a review in Nature [2011;7:74-75]. Magnetic resonance imaging (MRI) and immunologic biomarkers were identified to track the...
Treatment and monitoring of...
03/21/2011
First Report Managed Care
News Connection
Progression in Disability Status in Patients with Relapsing- Remitting MS
03/21/2011
The median age at onset of multiple sclerosis (MS) is approximately 30 years. Initially, the disease is often characterized by relapses and remissions, followed by a progressive worsening of neurologic function (secondary progressive MS). In...
The median age at onset of multiple sclerosis (MS) is approximately 30 years. Initially, the disease is often characterized by relapses and remissions, followed by a progressive worsening of neurologic function (secondary progressive MS). In...
The median age at onset of...
03/21/2011
First Report Managed Care
News Connection
Results of the CLARITY Study of Cladribine for the Treatment of MS
03/21/2011
Disease-modifying drugs currently available for the treatment of multiple sclerosis (MS), including various formulations of interferon beta (IFNβ ), glatiramer acetate, natalizumab, and mitoxantrone, require parenteral administration....
Disease-modifying drugs currently available for the treatment of multiple sclerosis (MS), including various formulations of interferon beta (IFNβ ), glatiramer acetate, natalizumab, and mitoxantrone, require parenteral administration....
Disease-modifying drugs...
03/21/2011
First Report Managed Care
News Connection
Dalfampridine and Walking Time for Selected Patients with Multiple Sclerosis
03/21/2011
Multiple sclerosis (MS) is a chronic and disabling disease of the central nervous system that affects nearly 400,000 Americans; approximately 200 people receive a diagnosis of MS each week. Worldwide, the number of people with the disease is...
Multiple sclerosis (MS) is a chronic and disabling disease of the central nervous system that affects nearly 400,000 Americans; approximately 200 people receive a diagnosis of MS each week. Worldwide, the number of people with the disease is...
Multiple sclerosis (MS) is a...
03/21/2011
First Report Managed Care
News Connection
No Improvement in Stone Expulsion Rate in Patients with Renal Colic Treated with Tamsulosin
03/21/2011
Results of a multicenter, randomized, double-blind trial [Arch Intern Med. 2010;170 (22):2021-2027] show that the adrenergic alpha-blocker tamsulosin did not accelerate the expulsion of distal ureteral stones in patients with renal colic.
Results of a multicenter, randomized, double-blind trial [Arch Intern Med. 2010;170 (22):2021-2027] show that the adrenergic alpha-blocker tamsulosin did not accelerate the expulsion of distal ureteral stones in patients with renal colic.
Results of a multicenter,...
03/21/2011
First Report Managed Care
News Connection
High Levels of Variability and Inconsistencies in Dosing Directions and Measuring Devices in Pediatric OTC Medications
03/21/2011
Results of a descriptive study of the top-selling 200 pediatric OTC medications on the market during 52 weeks found high levels of variability and inconsistency in dosing directions and measuring devices.
Results of a descriptive study of the top-selling 200 pediatric OTC medications on the market during 52 weeks found high levels of variability and inconsistency in dosing directions and measuring devices.
Results of a descriptive study...
03/21/2011
First Report Managed Care
News Connection
The Uninsured at Risk
03/21/2011
In 2009, the number of uninsured reached 50 million people nationwide. The 2010 Patient Protection and Affordable Care Act was designed to decrease the number of uninsured individuals by providing Medicaid or subsidizing coverage to...
In 2009, the number of uninsured reached 50 million people nationwide. The 2010 Patient Protection and Affordable Care Act was designed to decrease the number of uninsured individuals by providing Medicaid or subsidizing coverage to...
In 2009, the number of uninsured...
03/21/2011
First Report Managed Care
Feature
Rifaximin Improves Symptoms of Irritable Bowel Syndrome
03/21/2011
Results of two phase 3, double-blind, placebo-controlled, randomized clinical trials [N Engl J Med. 2011;364(1):22-32] show that patients with irritable bowel syndrome (IBS) treated with rifaximin for 2 weeks had significant improvements for...
Results of two phase 3, double-blind, placebo-controlled, randomized clinical trials [N Engl J Med. 2011;364(1):22-32] show that patients with irritable bowel syndrome (IBS) treated with rifaximin for 2 weeks had significant improvements for...
Results of two phase 3,...
03/21/2011
First Report Managed Care
FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

What's Trending?

News Connection
VA, CMS to Improve Safety Surveillance of Meds Given to Veterans
09/18/2019
The Department of Veteran Affairs and Centers for Medicare & Medicaid Services announced they will come together and work to improve drug safety monitoring of prescriptions, including opioids, that are given to veterans.
The Department of Veteran Affairs and Centers for Medicare & Medicaid Services announced they will come together and work to improve drug safety monitoring of prescriptions, including opioids, that are given to veterans.
The Department of Veteran...
09/18/2019
First Report Managed Care
News
U.S. pushes healthcare providers to share records electronically
03/12/2012
03/12/2012
First Report Managed Care
News
Boehringer CEO Says Negotiations With Sanofi to Be Complex
12/16/2015
Sanofi and Boehringer are in exclusive talks over a $20 billion swap of the French pharmaceuticals company's animal health business for the family-owned German group's consumer health operation.
Sanofi and Boehringer are in exclusive talks over a $20 billion swap of the French pharmaceuticals company's animal health business for the family-owned German group's consumer health operation.
Sanofi and Boehringer are in...
12/16/2015
First Report Managed Care
Commentary
Why Better Lab Management Is Key to Value-Based Care
11/16/2023
The health care community needs another tool to support its efforts to improve care while still managing testing use and costs. Lab benefit managers (LBMs) can provide the expertise to ensure the right tests are ordered at the right times to...
The health care community needs another tool to support its efforts to improve care while still managing testing use and costs. Lab benefit managers (LBMs) can provide the expertise to ensure the right tests are ordered at the right times to...
The health care community needs...
11/16/2023
First Report Managed Care
Preventive HIV Care to Be Covered by Health Plans, But Implementation Remains Confusing
Commentary
Preventive HIV Care to Be Covered by Health Plans, But Implementation Remains Confusing
01/11/2021
Russell Spjut, PharmD, owner of Formulary Intel Consulting, discusses the US Preventive Services Task Force’s measures to improve access to HIV preventive treatment, explains why the timing of health plan’s implementation has been scattered,...
Russell Spjut, PharmD, owner of Formulary Intel Consulting, discusses the US Preventive Services Task Force’s measures to improve access to HIV preventive treatment, explains why the timing of health plan’s implementation has been scattered,...
Russell Spjut, PharmD, owner of...
01/11/2021
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

March 2011 Volume 8 Issue 3

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use